In fact, ABC has been used for treating adult T cell leukemia (ATL), since ATL cells are unable to efficiently eliminate mis-incorporated ABC from the 3′ end of primers due to a defect in tyrosyl-DNA phosphodiesterase 1 (TDP1) [17]. The gene discussed is TDP1; the disease is adult T-cell leukemia/lymphoma.